Donepezil, a drug that is commonly used in treating Alzheimer’s disease and many forms of dementia has been associated with increased risk of hospitalization for rhabdomyolysis, a painful condition of muscle breakdown.
Rhabdomyolysis may also result in kidney-related diseases as well. Doctors suggest that the risk is low yet a statistically significant one.
Reference Link: https://scitechdaily.com/commonly-used-drug-for-alzheimers-disease-doubles-risk-of-hospitalization/